OSTEOARTHRITIS OF THE KNEES
Clinical trials for OSTEOARTHRITIS OF THE KNEES explained in plain language.
Never miss a new study
Get alerted when new OSTEOARTHRITIS OF THE KNEES trials appear
Sign up with your email to follow new studies for OSTEOARTHRITIS OF THE KNEES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to ease knee pain without surgery
Symptom relief Not yet recruitingThis early-stage study tests a drug called CX-011 injected into the knee to see if it safely reduces pain from osteoarthritis. About 72 adults with moderate to severe knee pain will receive the injection and be monitored for side effects and pain relief over 24 weeks. The goal is…
Matched conditions: OSTEOARTHRITIS OF THE KNEES
Phase: PHASE1, PHASE2 • Sponsor: CarthroniX, Inc. • Aim: Symptom relief
Last updated May 06, 2026 13:24 UTC
-
New knee pain drug AD-211 enters Mid-Stage trial
Symptom relief Not yet recruitingThis study tests a new drug called AD-211 for people with knee osteoarthritis. The goal is to find the best dose to reduce pain during activity. About 200 participants will receive either AD-211 or a placebo in a double-blind setup, meaning neither they nor their doctors will kno…
Matched conditions: OSTEOARTHRITIS OF THE KNEES
Phase: PHASE2 • Sponsor: Addpharma Inc. • Aim: Symptom relief
Last updated May 04, 2026 16:21 UTC